Akebia Therapeutics News, Akebia Therapeutics Quote, AKBA Quote

Akebia Therapeutics (NQ:AKBA) Delayed: 1.13 -0.05 (4.24%)

Prev. Close

$1.18

Open

$1.15

52 Wk High

$13.20

52 Wk Low

$7.00

Day High

$1.15

Day Low

$1.10

P/E

N/A

EPS

$0.00

Volume

1,167,891

Sep 6, 2023 08:00 AM Akebia Therapeutics to Present at H.C. Wainwright Global Investment Conference
Sep 5, 2023 04:05 PM Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 28, 2023 08:59 AM Form 10-Q Akebia Therapeutics, For: Jun 30
Aug 28, 2023 08:57 AM Form 10-K/A Akebia Therapeutics, For: Dec 31
Aug 28, 2023 06:07 AM H.C. Wainwright Upgrades Akebia Therapeutics (AKBA) to Buy, 'What we have been waiting for'
Aug 25, 2023 08:15 AM Form 8-K Akebia Therapeutics, For: Aug 25
Aug 25, 2023 08:10 AM Akebia Therapeutics (AKBA) Misses Q2 EPS by 3c
Aug 25, 2023 08:09 AM Akebia Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
Aug 24, 2023 08:02 AM Akebia Therapeutics (AKBA) Expects to Resubmit Vadadustat NDA in Third Quarter 2023
Aug 24, 2023 08:00 AM Akebia Therapeutics Expects to Resubmit Vadadustat NDA in Third Quarter 2023

Entities mentioned with AKBA